This inventor holds 4 USPTO granted patents. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 1990-1991.
Company Filing History:
Years Active: 1990-1991
Title: Innovations of Jagmohan Khanna in Antibiotic Production
Introduction
Jagmohan Khanna is a notable inventor based in New Delhi, India. He has made significant contributions to the field of antibiotic production, particularly through his innovative processes for the production of alpha-6-deoxytetracyclines. With a total of 4 patents to his name, Khanna's work has had a substantial impact on the pharmaceutical industry.
Latest Patents
Khanna's latest patents include a groundbreaking process for the production of alpha-6-deoxytetracyclines. This process involves the hydrogenation of a 6-methylenetetracycline in the presence of a transition metal complex, specifically designed to produce the antibiotic doxycycline. The method utilizes a transition metal complex of the formula MCl.sub.x (PPh.sub.3).sub.y, where M can be Cu, Co, or Ni, and incorporates a trace of rhodium as a hydrogenation catalyst. This innovative approach allows for high yields and stereospecificities while using substantially cheaper transition metal complexes.
Another significant patent by Khanna is a coordination compound that serves as a hydrogenation catalyst. This compound is particularly effective in the production of alpha-6-deoxytetracyclines, again focusing on the antibiotic doxycycline. The process emphasizes the use of minimal quantities of rhodium metal, enhancing the efficiency and cost-effectiveness of the production method.
Career Highlights
Jagmohan Khanna has been associated with Ranbaxy Laboratories, Inc., where he has played a crucial role in advancing antibiotic production technologies. His innovative approaches have not only contributed to the company's success but have also set new standards in the pharmaceutical industry.
Collaborations
Khanna has collaborated with notable colleagues such as Kiran Bala and Inder P Grover. Their combined expertise has further enhanced the research and development efforts in the field of antibiotic production.
Conclusion
Jagmohan Khanna's contributions to the field of antibiotic production through his innovative patents have made a significant impact on the pharmaceutical industry. His work continues to influence the development of more efficient and cost-effective methods for producing essential medications.